Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-07-29

Clinical Trial Update: Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating ursodeoxycholic acid for duodenal adenomas in familial adenomatous polyposis (FAP). The trial spans Phase 2 and Phase 3 with st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Adenomatous Polyposis Coli, Familial | Phase 2, Phase 3 | Status: UNKNOWN